In Sunday’s Outlook section of the Washington Post, Center for American Progress Senior Fellow Rick Weiss takes a close look at the personal impacts of new direct-to-consumer genetic testing services. He suggests that we need to properly regulate this auspicious technology to harness its benefits.
New research published this week indicates that a genetic mutation prevalent in individuals of African descent may increase susceptibility to HIV infection.
This week, the Howard Hughes Medical Institute stepped in with $600 million in grant funding to 56 biomedical researchers pursuing high-risk, high-return work. The federal government should also fund researchers who “swing for the fences.”
Presidents and candidates for the office voluntarily release their medical records. But with advances in screening and treatment for many kinds of medical conditions, how do we know we’re getting the full story on the health of the Commander-In-Chief? (And do we want it?)
The Associated Press reports that over 200 million children worldwide do not have access to basic health care. As a result, about 10 million children, most from the developing world, die each year from treatable illnesses.
One wonders how much of a public health crisis we need before we rethink our vaccine exemption policies—particularly given that misconceptions floating around about a connection between vaccines and autism are driving more parents to opt against MMR.
Dr. Arno Motulsky, who is now 87, essentially launched the field of pharmacogenomics, which studies how an individual’s genetic makeup affects his or her response to medication, in 1957. The New York Times Science section recently featured an interview with Dr. Motulsky, who has a hopeful but cautionary attitude about the future of genetic medicine.
PUBLIC HEALTH
Vaccine safety has grabbed headlines in recent months, as some parents, fearing alleged links to autism, exempt their children from vaccinations. Multiple studies have demonstrated there is no such link, but there is more to understand about how vaccines keep kids safe, and how public health ensure the safety of vaccines.
On Tuesday, the House Subcommittee on Oversight and Investigations held a hearing on a contaminant in blood thinner heparin that caused 81 deaths. Federal regulators now believe the contamination was deliberate, identifying a Chinese subsidiary of Scientific Protein Laboratories. It is no longer realistic to expect the FDA to make informed decisions if it does not have the resources to undertake foreign inspections.
Attention in the news to conflicts of interest within the medical profession seems to be on the rise. This is an issue that deserves serious scrutiny, particularly given how permissive the attitude of the medical community has been so far.
From an online survey of Nature readers comes data suggesting that a significant number of scientists and engineers use drugs for the non-medical purpose of increasing productivity and brain power.
A quick look at some of the policy-related posts in the science and technology blogosphere: suggestions for best practices in science blogging; the need for more hurricane research; vaccines and public fears; and new research centers to study parallel computing.
The improbability of an HIV vaccine, possibilities for improving scientific communication, and cheap laptops all made news at the American Association for the Advancement of Science annual meeting held this past weekend in Boston.
MEDICINE
In her latest book, Davis tackles the convoluted history of cancer research, revealing the extent to which governmental anti-cancer efforts were spearheaded by leaders from the very industries producing cancer-causing materials and products.
Is the NIH monitoring conflicts of interest?; EPA won’t explain itself on nixing state emissions caps; controversial framing of new MRSA study; new paths to energy-efficient electronics.
Greenland glaciers melting faster than previously thought; new money to fight African Sleeping Sickness; do plastic drinking bottles leech harmful chemicals?
Health coverage inequalities limit patient access to the free drugs pharmaceutical companies distribute, accelerate the illnesses of elderly patients, and limit access to preventative cancer screenings.
A cocaine vaccine; Navy sonar vs. the whales; racial gaps in ER painkiller prescriptions; Social Security Numbers available on the web; the EU’s Galileo geopositioning system.
Drug-resistant staph, known as MRSA, began making headlines in October, when the CDC released a report indicating that many healthy citizens carry the bacteria, which kills more people each year in the U.S. than AIDS. Two recent stories, one on research on a possible MRSA treatment and another on the threat of the bacteria on factory farms, may put the “superbug” back under the public microscope.
A profile of Shinya Yamanaka; developing a malaria vaccine; providing an overdose antidote to heroin addicts; the Nobel Peace Prize acceptance speeches.
Science Progress and American Progress's Doing What Works project teamed up to produce a set of policy proposals that the Obama administration and Congress can adopt to reinvest in the building blocks of American science, innovation, and economic competitiveness. Read the overview of the five reports.
Science Progress proceeds from the propositions that scientific inquiry is among the finest expressions of human excellence, that it is a crucial source of human flourishing, a critical engine of economic growth, and must be dedicated to the common good. Scientific inquiry entails global responsibilities. It should lead to a more equitable, safer, and healthier future for all of humankind.